XML 57 R37.htm IDEA: XBRL DOCUMENT

Debt (Details Narrative)	Apr. 08, 2021 USD ($) $ / shares shares
Common stocks issued \| shares	26,042
Common stock Exercise price \| $ / shares	$ 14.40
Debt issuance costs	$ 500,000
Lendor [Member]
Agreed to pay loan	25,000,000
Security and Loan agreement [Member] \| Innovatus Life Sciences [Member]
Term B loan to be funded before March 31, 2022	5,000,000
Non contingent term A loan, funded	15,000,000.0
Line of credit faciltiy, maximum borrowing capacity	25,000,000
Term C loan to be funded before March 31, 2023	$ 5,000,000
Common stock shares issuable upon exercise of warrants \| shares	26,042
Additional debt discount recognized	$ 300,000
Term loans, interest rate	11.36%
Term loans, interest, payable in kind	2.7%
Non refundable facility fee payable to lender, percentage	1.00%
Final fee payable to lender, percentage	4.50%
Non refundable facility fee payable to lender, amount	$ 700,000
Final fee payable to lender, amount	$ 100,000